Literature DB >> 6628374

Susceptibility of gram-positive aerobic cocci to the new cephalosporin HR 810.

A Bauernfeind.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6628374     DOI： 10.1007/bf02019468

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN： 0722-2211            Impact factor:   3.267


× No keyword cloud information.
  3 in total

1.  A simple test system for the separation of staphylococci from micrococci.

Authors:  K H Schleifer; W E Kloos
Journal:  J Clin Microbiol       Date:  1975-03       Impact factor: 5.948

2.  Comparative activities of 13 beta-lactam antibiotics.

Authors:  H L Muytjens; J van der Ros-van de Repe
Journal:  Antimicrob Agents Chemother       Date:  1982-06       Impact factor: 5.191

3.  In vitro activity of teichomycin A 2 in comparison with penicillin and vancomycin against gram-positive cocci.

Authors:  A Bauernfeind; C Petermüller
Journal:  Eur J Clin Microbiol       Date:  1982-10       Impact factor: 3.267
  3 in total
  11 in total

1.  Antimicrobial activity of HR810 against 419 strict anaerobic bacteria.

Authors:  R N Jones; E H Gerlach
Journal:  Antimicrob Agents Chemother       Date:  1985-03       Impact factor: 5.191

2.  In vitro activity of HR 810, a new cephalosporin.

Authors:  M A Bertram; D A Bruckner; L S Young
Journal:  Antimicrob Agents Chemother       Date:  1984-08       Impact factor: 5.191

3.  In vitro evaluation of HR810, a new wide-spectrum aminothiazolyl alpha-methoxyimino cephalosporin.

Authors:  R N Jones; C Thornsberry; A L Barry
Journal:  Antimicrob Agents Chemother       Date:  1984-06       Impact factor: 5.191

Review 4.  Cefmenoxime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Campoli-Richards; P A Todd
Journal:  Drugs       Date:  1987-08       Impact factor: 9.546

5.  Activity of cefpirome combined with beta-lactamase inhibitors and affinity for the penicillin-binding proteins of methicillin-resistant Staphylococcus aureus.

Authors:  L J Piddock; E A Traynor; D J Griggs
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-04       Impact factor: 3.267

6.  In vitro antimicrobial activity of cefpirome against ceftazidime-resistant isolates from two multicenter studies.

Authors:  H S Sader; R N Jones
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-08       Impact factor: 3.267

7.  The in vitro activity and beta-lactamase stability of cefpirome (HR 810), a pyridine cephalosporin agent active against staphylococci, Enterobacteriaceae and Pseudomonas aeruginosa.

Authors:  H C Neu; N X Chin; P Labthavikul
Journal:  Infection       Date:  1985 May-Jun       Impact factor: 3.553

8.  Beta-lactamase stability of cefpirome (HR 810), a new cephalosporin with a broad antimicrobial spectrum.

Authors:  S Kobayashi; S Arai; S Hayashi; K Fujimoto
Journal:  Antimicrob Agents Chemother       Date:  1986-11       Impact factor: 5.191

9.  In vitro activity of HR 810, a new broad-spectrum cephalosporin.

Authors:  K Machka; I Braveny
Journal:  Eur J Clin Microbiol       Date:  1983-08       Impact factor: 3.267

10.  Comparative study of pharmacokinetics and serum bactericidal activities of cefpirome, ceftazidime, ceftriaxone, imipenem, and ciprofloxacin.

Authors:  D Paradis; F Vallée; S Allard; C Bisson; N Daviau; C Drapeau; F Auger; M LeBel
Journal:  Antimicrob Agents Chemother       Date:  1992-10       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.